Applied Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '19 Dec 31, 2019	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Net Income	-2.79	-2.63	-2.38	-0.52	-0.1
Depreciation & Amortization	0.18	0.04	0.22	0.02	-
Other Amortization	0.19	0.5	-	-	-
Asset Writedown & Restructuring Costs	-	-	0.89	-	-
Loss (Gain) From Sale of Investments	0.3	-0.43	-	-	-
Stock-Based Compensation	0.47	1.41	0.61	-	-
Other Operating Activities	-0.24	-0.05	-0.01	0.38	-
Change in Accounts Receivable	0.04	-0.02	-0.01	-0.01	-
Change in Inventory	-0.03	-0.05	-0.01	-0.02	-
Change in Accounts Payable	0.67	0.04	0	0.02	0.03
Change in Other Net Operating Assets	0.24	0.29	-0	-0.02	-
Operating Cash Flow	-0.93	-0.91	-0.67	-0.14	-0.07
Capital Expenditures	-0	-0	-0	-	-
Cash Acquisitions	-0.16	-0.71	-	-0.33	-
Sale (Purchase) of Intangibles	-	-	-	-0.15	-
Investment in Securities	-	-	-0.17	-0.3	-
Investing Cash Flow	-0.16	-0.71	-0.17	-0.78	-
Short-Term Debt Issued	-	1.53	-	-	-
Total Debt Issued	0.88	1.53	-	-	0.07
Net Debt Issued (Repaid)	0.88	1.53	-	-	0.07
Issuance of Common Stock	-	0.08	0.8	1.13	-
Repurchase of Common Stock	-	-	-0.1	-	-
Financing Cash Flow	0.88	1.6	0.7	1.13	0.07
Net Cash Flow	-0.22	-0.01	-0.15	0.21	-
Free Cash Flow	-0.94	-0.91	-0.68	-0.14	-0.07
Free Cash Flow Margin	-108.79%	-128.22%	-343.28%	-301.76%	-
Free Cash Flow Per Share	-0.07	-0.08	-0.04	-0.01	-0.01
Levered Free Cash Flow	-0.09	0.06	-0.22	-	-
Unlevered Free Cash Flow	-0.13	-0.04	-0.22	-	-
Change in Net Working Capital	-0.89	-0.17	0.12	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.